← Evidence map

ArticleNature reviews. Clinical oncology2024

The MARIPOSA trials - implications for the treatment of EGFR-mutant NSCLC.

Fatemeh Ardeshir-Larijani et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39160242